Sales expenses of selected Chinese pharma companies 2021-2022
The Chinese pharmaceutical companies invested between 8.6 to 36.22 percent of their sales revenue in sales, distribution and marketing. In 2021, the sales expenses of Jiangsu Hengrui Medicine amounted to about 9.38 billion yuan.